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Abstracts / Urological Science 26 (2015) S36eS49S44from local clinic due to persistent left ﬂank pain. However, she gradually
experienced high fever, dyspnea and general weakness, and was then
admitted to other hospital 10 days after falling down. Septic work up was
done and prophylaxis antibiotic was prescribed there, and initial CXR
revealed bilateral lung patchy inﬁltrates and consolidations. Abdominal
and chest CT with contrast enhancement showed: (1) multiple wedge
shape and nodular patches over both lung ﬁeld, favor septic pulmonary
embolism, and (2) left renal infarct with huge sub-capsular hematoma and
renal vein thrombosis, favor acute pyelonephritis with thrombophlebitis.
Due to the suspicious of renal origin related septic pulmonary embolism,
she was referred to our hospital for further management.
At our emergent department, ECG was performed to rule out atrial ﬁbril-
lation related pulmonary embolization. Whole body CT with angiography
was performed again, which revealed similar result without other possible
origin of the emboli. Emergent left radical nephrectomy was carried out to
avoid further thrombus formation. Huge sub-capsular hematoma was
found on the specimen, but the renal vein thrombosis disappeared. During
the post-operative period in the intensive-care unit, the lung condition
gradually improved, and the fever gradually subsided under antibiotic
treatment. Extubation was done smoothly a few days later before trans-
ferring to the general ward. The patient was then discharged 20 days after
the surgery. All culture results in our hospital including blood, urine, renal
hematoma and broncho-alveolar lavage were negative ﬁndings (blood
culture in the ﬁrst-admitted hospital showed GNB). Final pathology
revealed (1) hemorrhagic infarct, and (2) acute suppurative inﬂammation
with abscess formation.
Conclusion: Blunt renal trauma with main vascular injury includes
laceration, avulsion or thrombosis, is classiﬁed as grade V according to
the current grading system. However, renal vein thrombosis is also an
uncommon complication of acute pyelonephritis or diabetic nephropa-
thy. It was difﬁcult to tell which factor really caused the renal vein
thrombosis in this patient, and ﬁnally resulted in septic pulmonary
embolism. Anticoagulating therapy or thrombolytic therapy is contra-
indicated in this patient due to the concern of recurrent renal bleeding,
and therefore surgical exploration for radical nephrectomy is an optimal
choice.Moderated Poster-4#Oncology
MP4-1.
COMPARISONS OF ONCOLOGICAL AND FUNCTIONAL OUTCOMES
BETWEEN PRIMARY WHOLE-GLAND CRYOABLATION AND HIGH-
INTENSITY FOCUSED ULTRASOUND FOR LOCALIZED PROSTATE CANCER
Yi Yang Liu 1, Po Hui Chiang 2. 1Department of Urology, Yunlin Chang Gung
Memorial Hospital, Yunlin, Taiwan; 2Department of Urology, Kaohsiung
Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Purpose: To conduct a prospective, single institutional comparison for
primary whole-gland cryoablation and high-intensity focused ultrasound
(HIFU) in localized prostate cancer with respects to oncological and
functional outcomes.
Materials and methods: We enrolled 114 and 120 patients of primary
whole-gland cryoablation and HIFU for localized prostate cancer from
October 2008 to December 2013. PSA biochemical recurrence deﬁned by
Phoenix deﬁnition, salvage treatment-free rate, metastasis-free rate, and
PSA biochemical recurrence-free survival analyzed by Kaplan-Meier
method were for oncological outcomes. Functional outcomes included
complications and serial IIEF-5 scores, IPSS and related QoL scores.
Results: During the mean follow-up duration of about 2 years, the PSA
biochemical recurrence rates of the two groups were similar (cryoa-
blation 25.4%, HIFU 18.3%). In terms of functional outcomes, the patients
of HIFU had signiﬁcantly lower IPSS (5.70 vs 9.04 at 24 months,
P ¼ 0.030), lower erectile dysfunction rate (65.6% vs 88.0%, P ¼ 0.015) and
higher IIEF-5 score (9.36 vs 4.18 at 24 months, P ¼ 0.028) than did the
patients of cryoablation.Conclusion: In this study, both primary whole-gland cryoablation and
HIFU demonstrated good oncological outcomes for localized prostate
cancer. Besides, we validated the safety of the two treatment modalities
and identiﬁed the importance of combined HIFU and TURP. The HIFU pa-
tients experienced better urinary function improvement and more
possible sexual function preservation than did the cryoablation patients;
therefore, HIFU may provide better quality of life for patients of localized
prostate cancer.
MP4-2.
URINARY BLADDER RECURRENCE AFTER NEPHROURETERECTOMY FOR
UPPER TRACT UROTHELIAL CARCINOMA
Shih-Feng Wang, Chu-Hsuan Hung, Shu-Wei Tsai, Wah-On Lo, Yen-Chieh
Wang, Kuo-Chiang Chen, Teh-Sheng Hsieh, Chih-Ming Lin. Divisions of
Urology, Department of Surgery, Cathay General Hospital, Taipei, Taiwan
Purpose: We investigate the factors association with the urinary bladder
recurrence after nephroureterectomy (NU) for upper tract urothelial car-
cinoma (UTUC).
Materials and methods: We retrospectively reviewed our experience of
the patients who accepted NU for UTUC from Jan 1997 to Dec 2014. We
analyzed risk factors of the urinary bladder recurrence after resection of
kidney, ureter, and bladder cuff.
Results: During this 8-year period, 149 patients accepted NU for UTUC. 16
patients were excluded due to the combination with radical cystectomy,
incomplete medical records, or loss of follow up. 33 (24.8%) patients had
urinary bladder recurrence, and the mean duration from NU to recurrence
was 11.39 months (2 e 38 months). We evaluated the recurrence-free
survival (RFS) with Kaplan-Meier survival analysis. Laparoscopic NU had
similar RFS with open NU (p ¼ 0.714). Regarding to the management
method of bladder cuff, there was no difference about the RFS between
pluck procedure and traditional extravesical bladder cuff resection
(p ¼ 0.586). Histology grade of cancer cell had no inﬂuence on the RFS
(p ¼ 0.551). The cancer stage 0a (pTa) had signiﬁcant longer bladder RFS
than other stages (p ¼ 0.024).
Conclusions: Laparoscopic NU and pluck procedure for bladder cuff
resection are safe and effective technique for the management of UTUC.
Cancer stage other than pTa have higher bladder recurrence rate and
shorter RFS.
MP4-3.
MIR-99A ACTS AS TUMOR SUPPRESSOR VIA TARGETING TO mTOR in
human bladder cancer cells
Kuang-Yu Chou 1,4,#, Ji-Fan Lin 2,#, Te-Fu Tsai 1,4, Hung-En Chen 1, Yi-Chia
Lin 1,4, Thomas I-Sheng Hwang 1,3,4. 1Division of Urology, Department of
Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taiwan; 2Central
Laboratory, Shin Kong Wu Ho-Su Memorial Hospital, Taiwan; 3Department
of Urology, Taipei Medical University, Division of Urology, Taiwan; 4 School
of Medicine, Fu-Jen Catholic University, Taipei, Taiwan
Purpose: mTOR is recognized as an important target in many cancer
types. In our previous studies, mTOR inhibitor Everolimus (RAD001)
caused severed cell viability lost only when the induced-autophagy
was coordinately inhibited in bladder cancer cells. The mTOR complex
2 (mTORC2) containing mTOR and rictor is thought to be insensitive to
RAD001 and was shown to regulate the prosurvival kinase AKT by
phosphorylation on Ser473. Therefore, novel inhibitors that inhibit
both mTORC1 and mTORC2 are warrant to treat bladder cancer. We
previously showed that the expression level of miR-99a was down-
regulated in human bladder tumor tissues compared to their adjacent
normal tissues. Since mTOR is predicted to be a potential target of miR-
99a, we investigate the anti-cancer activity of miR-99a in bladder
cancer cells.
Materials and methods: Vectors that express miR-99a were transfected
into human bladder (5637 and T24) cells. Expression level of miR-99a
was monitored by miRNA Q-PCR. 30-UTR of mTOR was constructedThese authors contributed equally to this work.
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performed to verify the direct binding of miR-99a to mTOR transcripts.
The mRNA and protein expression level of mTOR were measured by Q-
PCR and Western blot, respectively. Cell viability of miR-99a transfected
cells was detected by WST-1 and colony formation assays. Inhibition of
mTOR complex 1 and 2 (mTORC1 and mTORC2) signaling was moni-
tored by detecting the phosphorylation of S6K and Akt using Western
blot. Induction of autophagy was accessed by the expression of LC3-II
marker protein.
Results: Transfection of miR-99a expressing vector elevated the
expression level of miR-99a up to 4.5-fold in cells compared to vector-
only control. The function of matured miR-99a was conﬁrmed by
luciferase reporter assays. The level of mTOR RNA and protein were
decreased in miR-99a transfected cells. Dual inhibition of mTORC1 and
mTORC2 was conﬁrmed by immunoprecipitation (IP) of mTOR associ-
ated Rictor and Raptor, and the decreased phosphorylation of S6K and
Akt in miR-99a transfected cells. The LC3-II protein was accumulated in
miR-99a transfected cells compared to monk transfected control, sug-
gesting that inhibition of mTOR by miR-99a induces autophagy in
bladder cancer cells.
Conclusions: This is the ﬁrst study showed that miR-99a markedly in-
hibits bladder cancer cell growth via dual inhibition of mTORC1 and
mTORC2. miR-99a treatment also induces autophagy through mTOR in-
hibition. However, the role of miR-99a induces autophagy remains further
investigation.
MP4-4.
BLUE-LIGHT EXPOSURE ACCELERATES PHOTO-OXIDATIVE DISRUPTION
OF LYSOSOMAL MEMBRANES AND APOPTOSIS IN ACRIDINE ORANGE-
LOADED CHLOROQUINE-TREATED HUMAN BLADDER CANCER CELLS
Yi-Chia Lin 1,3, Ji-Fan Lin 2, Te-Fu Tsai 1,3, Hung-En Chen 1, Kuang-Yu
Chou 1,3, Thomas I-Sheng Hwang 1,3. 1Division of Urology, Department of
Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan; 2Central
Laboratory, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan;
3 School of Medicine, Fu-Jen Catholic University, Taipei, Taiwan
Introduction: We previously showed that human bladder cancer cells
exhibited high basal level of autophagic activity. Administration of chlo-
roquine (CQ) or hydroxychloroquine (HCQ) inhibits autophagy and causes
apoptotic cell death in bladder cancer cells. Acridione orange (AO) is
commonly used to identify acidic vescular organelles (AVOs) in autophagic
cells. The uncharged state of AO in cells was characterized by green ﬂuo-
rescence; while protonated form of AO accumulates in acidic compart-
ments and forms aggregates that characterized by red ﬂuorescence. An
incidentally found disruption of the lysosome under treatment of CQ and
blue light was observed. An experiment was conducted to verify the
phenomenon is meaningful.
Methods: Inhibition of basal autophagy was achieved using CQ inT24
human bladder cancer cell lines by detecting LC3-II formation. Acridine
orange relocalization was performed in T24 cells with or without CQ
treatment for 2 hours. Immunoﬂuorescence and Western blot were used
for detection of cathepsin B and D release from lysosome. Cell viability and
induction of cell death were detected using ApoTox-Glo Triplex Assay kit
from Promega.
Results: CQ inhibited basal autophagy and decreased cell viability in T24
cells. AO relocalization was detected only in CQ-treated T24 cells. CQ-
treated T24 cells that exposed for a short period of time to AO and under
ordinary culture condition, accumulate the AOwithin AVOs, giving rise to a
mainly red, granular ﬂuorescence upon excitation with blue light. When
AO-loaded CQ-treated cells are irradiated with intense blue light, AO soon
starts to leak from lysosomes to nuclear and cytosol diffusely. Severe
lysosomal damage that causing necrosis and apoptosis was only detected
in AO-loaded CQ-treated T24 cells. This photo-oxidative disruption of
lysosome was responsible for triggering cell death in bladder cancer cells.
Necrotic and apoptotic death were both detected in cell treated with CQ up
to 50%.
Conclusions: Photo-oxidative disruption of lysosomal membrane with
AO and CQ may be an effective cancer therapy in human bladder
cancer.MP4-5.
THE APPLICATION OF SPIES IN THE DIAGNOSIS AND TREATMENT OF
BLADDER UROTHELIAL CARCINOMA-THE PRELIMINARY REPORT IN
TAIPEI CITY HOSPITAL
Thomas Y. Hsueh 1,3,4, Andy C. Huang 1,4, Yu-Wei Lai 1, Shiou-Sheng
Chen 1,4, Yi-Chun Chiu 2,4, Allen W. Chiu 1,4. 1Division of Urology,
Department of Surgery, Taipei City Hospital, Ren-Ai Branch, Taiwan;
2Division of Urology, Department of Surgery, Taipei City Hospital,
Zhongxiao Branch, Taiwan; 3Department of Education and Research, Taipei
City Hospital, Taiwan; 4Department of Urology, School of Medicine,
National Yang-Ming University, Taipei, Taiwan
Purpose: To report our preliminary experience regarding the application
of SPICE technology in the diagnosis and treatment of bladder urothelial
carcinoma.
Patients and methods: A prospective randomized trial will be conducted
from January 2015 to May 2015. A total of 30 patients with bladder uro-
thelial carcinoma will be enrolled into this study. All patients received
standard cystoscopy followed by SPICE technology cystoscopy. The num-
ber of tumor was counted under direct vision by two experienced urolo-
gists. All patients received transurethral resection of bladder tumor. All
patients received standard treatment protocol and followed every 3
months using standard cystoscopy.
Results: The number of tumor diagnosed under standard cystoscopy or
SPICE technology cystoscopy will be compared in this study. The incidence
of tumor recurrence and metastasis will be calculated in this study.
Conclusion: Cystoscopy empowered with SPICE technology will be a
viable option to assist the diagnosis and treatment of bladder urothelial
carcinoma.
MP4-6.
TOLL-LIKE RECEPTOR 6 AND CONNECTIVE TISSUE GROWTH FACTOR
ARE SIGNIFICANTLY UPREGULATED IN MITOMYCIN-C-TREATED
UROTHELIAL CARCINOMA CELLS UNDER HYDROSTATIC PRESSURE
STIMULATION
Shao Kuan Chen. Sijhih Cathay General Hospital, Taiwan
Purpose: Urothelial carcinoma (UC) is the most common histologic sub-
type of bladder cancer. The administration of mitomycin C (MMC) into
bladder after transurethral resection of the bladder tumor (TURBT) is a
common treatment strategy for preventing recurrence after surgery. We
previously applied hydrostatic pressure combined with MMC in UC cells
and found that hydrostatic pressure synergistically enhanced MMC-
induced UC cell apoptosis via the Fas/FasL pathways.
Materials and methods: To understand the alteration of gene expressions
in UC cells caused by hydrostatic pressure and MMC, oligonucleotide
microarray was used to explore all of the differentially expressed genes.
Results: After bioinformatics analysis and gene annotation, toll-like re-
ceptor 6 (TLR6) and connective tissue growth factor (CTGF) showed sig-
niﬁcant up-regulation among altered genes, and their gene and protein
expressions with each treatment of UC cells were validated by quantitative
real-time PCR and immunoblotting.
Conclusion: Under treatment with MMC and hydrostatic pressure, UC
cells showed increasing apoptosis via extrinsic pathways through upre-
gulation of TLR6 and CTGF.
MP4-7.
CLINICAL OUTCOMES IN CASTRATION RESISTANT PROSTATE CANCER
PATIENTS TREATING WITH CABAZITAXEL
Jen-Hao Cheng, Shian-Shiang Wang, Cheng-Kuang Yang, Yen-Chuan
Ou, Chuan-Shu Chen, Jian-Ri Li. Divisions of Urology, Department of
Surgery, Taichung Veterans General Hospital, Taichung, Taiwan
Purpose: The aim of this study was to assess the clinical outcomes of
Cabazitaxel in treating castration resistant prostate cancer patients in
Taichung Veterans General Hospital.
Materials and methods: From Aug 2011 to Dec 2014, thirty-two patients
with castration resistant prostate cancer were treated with Cabazitaxel 20-
